The protein therapeutics market is poised to grow by USD 82.47 bn during 2020-2024, progressing at a CAGR of over 7% during the forecast period.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201203005497/en/
Technavio has announced its latest market research report titled Global Protein Therapeutics Market 2020-2024 (Graphic: Business Wire)
Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Get FREE Sample Report in Minutes!
The report on the protein therapeutics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by increased demand for mAbs.
The protein therapeutics market analysis includes product segment and geography landscape. This study identifies the development of novel therapies using innovative technologies as one of the prime reasons driving the protein therapeutics market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The protein therapeutics market covers the following areas:
Protein Therapeutics Market Sizing
Protein Therapeutics Market Forecast
Protein Therapeutics Market Analysis
Companies Mentioned
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Johnson Johnson
- Merck Co. Inc.
- Novo Nordisk AS
- Pfizer Inc.
- Sanofi
Related Reports on Health Care Include:
- Point of Care Diagnostics Market by Product, End-user, and Geography Forecast and Analysis 2020-2024- The point of care diagnostics market size has the potential to grow by USD 10.69 billion during 2020-2024. However, the market's growth momentum will decelerate during the forecast period. To get extensive research insights: Click and get a FREE sample report in minutes
- Prostate Biopsy Market by Product, End-user, and Geography Forecast and Analysis 2020-2024- The prostate biopsy market size has the potential to grow by USD 380.23 million during 2020-2024, and the market's growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get a FREE sample report in minutes
Key Topics Covered:
Executive Summary
Market Landscape
- Market ecosystem
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 2024
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- mAbs Market size and forecast 2019-2024
- Human insulin Market size and forecast 2019-2024
- Erythropoeitin Market size and forecast 2019-2024
- Clotting factors Market size and forecast 2019-2024
- Others Market size and forecast 2019-2024
- Market opportunity by Product
Market segmentation by Therapy Area
- Market segments
- Metabolic and endocrine disorders
- Hematopoiesis
- Fertility
- Cancer
- Autoimmune diseases
- Infectious diseases
- Protein vaccine
Market segmentation by Protein Function
- Market segments
- Enzymatic and regulatory activity
- Special targeting activity
- Vaccines
- Protein diagnostics
Customer Landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America Market size and forecast 2019-2024
- Europe Market size and forecast 2019-2024
- APAC Market size and forecast 2019-2024
- South America Market size and forecast 2019-2024
- MEA Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Johnson Johnson
- Merck Co. Inc.
- Novo Nordisk AS
- Pfizer Inc.
- Sanofi
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201203005497/en/
Contacts:
Technavio Research
Jesse Maida
Media Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/